MicroPort® UniFlow Streamliner™ Implantable Tibial Nerve Stimulator
Urinary Incontinence
Regulatory Review (NMPA Green Path)Active
Key Facts
About MicroPort
MicroPort is a mission-driven global medical device company with the goal of providing trustworthy, universal access to state-of-the-art solutions that prolong and reshape lives. Founded in 1998, it has grown into a diversified powerhouse with eight core business units, achieving significant regulatory milestones and commercial successes, including over 10 million coronary stent systems shipped and over 100 installations of its Toumai® surgical robot. Its strategy is built on a federated model of focused subsidiaries, a global R&D and manufacturing footprint, and a proprietary industrial ecosystem designed to foster innovation and streamline market access.
View full company profileTherapeutic Areas
Other Urinary Incontinence Drugs
| Drug | Company | Phase |
|---|---|---|
| Mirabegron Intermediate | AR Life Science | Commercial |
| Autologous Cell Therapy for Urinary Incontinence | Innovacell Biotechnologie | Clinical Development |